Vision recovery similar at 30 days, consistent with other recent randomized studies ...

Central retinal artery occlusion (CRAO) is an ophthalmic emergency that usually leads to sudden and permanent blindness, and ...

Intravenous tenecteplase administered within 4.5 hours after onset of central retinal artery occlusion does not improve vision recovery at 30 days compared with oral aspirin, according to a study ...

In this expert perspective from Retina 2026, Sharon Fekrat, MD, FACS, FASRS, discusses a real-world retrospective analysis of the Vestrum Health Retina Database of patients with retinal vein occlusion ...

Central retinal artery occlusion can result in permanent vision loss. Effective treatment is lacking. We conducted a phase 3, double-blind, double-dummy, randomized, controlled trial involving ...

Real-world, 12-month results demonstrated efficacy, safety and durability for faricimab as a treatment for retinal vein occlusion, according to a speaker at Retina 2026.In light of faricimab’s ...

Annexin Pharmaceuticals AB today announces favourable findings in the company's ongoing Proof of Concept Phase 2a study with the drug candidate ANXV in Diabetic Retinopathy (DR) and Retinal Vein Occlu ...

Trainers reveal how this low-impact walking method builds muscle and accelerates recovery.

Background: Atopic dermatitis (AD) may be exacerbated by occlusion from items such as occlusive gloves or textiles, especially if the occlusion is removed suddenly, creating a steep humidity gradient.

Global Transcatheter Embolization and Occlusion Devices Market to Expand at 8.66% CAGR as Demand for Minimally Invasive Vascular and Cancer Therapies Accelerates.Austin, Texas, Jan. 27, 2026 (GLOBE ...

Intravenous tenecteplase does not improve vision recovery and is associated with greater incidence of adverse events ...